BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 35759451)

  • 1. METTL3-mediated m6A modification promotes processing and maturation of
    Gong Y; Jiang Q; Liu L; Liao Q; Yu J; Xiang Z; Luo X
    Physiol Genomics; 2022 Sep; 54(9):337-349. PubMed ID: 35759451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of METTL3-mediated m6A modification in depression-induced cognitive deficits.
    Niu J; Wang B; Wang T; Zhou T
    Am J Med Genet B Neuropsychiatr Genet; 2022 Apr; 189(3-4):86-99. PubMed ID: 35591810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP.
    Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y
    Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
    Li S; Lu X; Zheng D; Chen W; Li Y; Li F
    J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyltransferase-like 3-mediated m6A modification of miR-1908-5p contributes to nasopharyngeal carcinoma progression by targeting homeodomain-only protein homeobox.
    Zhou Y; Li W
    Environ Toxicol; 2024 Mar; 39(3):1631-1640. PubMed ID: 38018881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-Methyladenosine reader HNRNPC-mediated downregulation of circITCH prevents miR-224-3p sequestering and contributes to tumorigenesis in nasopharyngeal carcinoma.
    Zhou Q; Song W; Li X; Lin J; Zhu C; Cao L; Li W; Lin S
    Environ Toxicol; 2024 May; 39(5):2893-2907. PubMed ID: 38299319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer.
    Liang X; Zhang Z; Wang L; Zhang S; Ren L; Li S; Xu J; Lv S
    Bioengineered; 2021 Dec; 12(2):10023-10036. PubMed ID: 34666602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression.
    Qian K; Xu W; Xia X; Ding J
    Genes Genomics; 2022 Dec; 44(12):1519-1530. PubMed ID: 36040683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing METTL3 Stabilizes Atherosclerotic Plaques by Regulating the Phenotypic Transformation of Vascular Smooth Muscle Cells via the miR-375-3p/PDK1 Axis.
    Chen J; Lai K; Yong X; Yin H; Chen Z; Wang H; Chen K; Zheng J
    Cardiovasc Drugs Ther; 2023 Jun; 37(3):471-486. PubMed ID: 35704246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of METTL14-mediated m
    Gong S; Wang S; Shao M
    J Mol Med (Berl); 2022 Dec; 100(12):1771-1785. PubMed ID: 36352154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
    Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H
    Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.
    Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G
    Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The m6A methyltransferase METTL3 aggravates the progression of nasopharyngeal carcinoma through inducing EMT by m6A-modified Snail mRNA.
    Yu X; Zhao H; Cao Z
    Minerva Med; 2022 Apr; 113(2):309-314. PubMed ID: 32512975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated METTL3 in nasopharyngeal carcinoma enhances the motility of cancer cells.
    Liu ZF; Yang J; Wei SP; Luo XG; Jiang QS; Chen T; Gong YQ
    Kaohsiung J Med Sci; 2020 Nov; 36(11):895-903. PubMed ID: 32668092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
    Cui Z; Zhao Y
    BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.
    Zhang BY; Han L; Tang YF; Zhang GX; Fan XL; Zhang JJ; Xue Q; Xu ZY
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):7015-7023. PubMed ID: 32633395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.
    Song L; Chen L; Luan Q; Kong Q
    J Cell Physiol; 2019 Aug; 234(10):17912-17924. PubMed ID: 30834525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-199a-3p suppresses the invasion and metastasis of nasopharyngeal carcinoma through SCD1/PTEN/AKT signaling pathway.
    Hu W; Wang Y; Zhang Q; Luo Q; Huang N; Chen R; Tang X; Li X; Luo H
    Cell Signal; 2023 Oct; 110():110833. PubMed ID: 37543098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p.
    Liu Z; Liu F; Wang F; Yang X; Guo W
    Mol Cell Biochem; 2021 Jan; 476(1):175-186. PubMed ID: 32970285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-302a-3p suppresses melanoma cell progression via targeting METTL3.
    Chang X; Lin YY; Bai LN; Zhu W
    J Chemother; 2022 Feb; 34(1):55-66. PubMed ID: 34286671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.